Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01979471Not ApplicableCompleted

The Alberta Vascular Risk Reduction Community Pharmacy Project: RxEACH

Role: collaborator

NCT01328639Not ApplicableCompleted

TeamCare PCN: Collaborative Care for Diabetes and Depression

Role: collaborator

NCT00277186Not ApplicableCompleted

Alberta Hip and Knee Replacement Project

Role: collaborator

NCT00374270Phase 4Completed

Improving Blood Pressure Management in Patients With Diabetes

Role: collaborator

All 4 trials loaded